Literature DB >> 27528759

Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?

Giulio Laurenti1, Daniel A Tennant2.   

Abstract

In the early 1920s Otto Warburg observed that cancer cells have altered metabolism and from this, posited that mitochondrial dysfunction underpinned the aetiology of cancers. The more recent identification of mutations of mitochondrial metabolic enzymes in a wide range of human cancers has now provided a direct link between metabolic alterations and cancer. In this review we discuss the consequences of dysfunction of three metabolic enzymes involved in or associated with the tricarboxylic acid (TCA) cycle: succinate dehydrogenase (SDH), fumarate hydratase (FH) and isocitrate dehydrogenase (IDH) focusing on the similarity between the phenotypes of cancers harbouring these mutations.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  cancer metabolism; fumarate hydratase; hypoxia; isocitrate dehydrogenase; reactive oxygen species (ROS); succinate dehydrogenase

Mesh:

Substances:

Year:  2016        PMID: 27528759     DOI: 10.1042/BST20160099

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  23 in total

1.  Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.

Authors:  Albino Bacolla; Zu Ye; Zamal Ahmed; John A Tainer
Journal:  Prog Biophys Mol Biol       Date:  2019-03-14       Impact factor: 3.667

2.  Tolerance of DNA Replication Stress Is Promoted by Fumarate Through Modulation of Histone Demethylation and Enhancement of Replicative Intermediate Processing in Saccharomyces cerevisiae.

Authors:  Faeze Saatchi; Ann L Kirchmaier
Journal:  Genetics       Date:  2019-05-13       Impact factor: 4.562

Review 3.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

4.  Homozygous mutation, p.Pro304His, in IDH3A, encoding isocitrate dehydrogenase subunit is associated with severe encephalopathy in infancy.

Authors:  Aviva Fattal-Valevski; Hila Eliyahu; NItai D Fraenkel; Ganit Elmaliach; Moran Hausman-Kedem; Avraham Shaag; Dror Mandel; Ophry Pines; Orly Elpeleg
Journal:  Neurogenetics       Date:  2017-01-05       Impact factor: 2.660

Review 5.  Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.

Authors:  Jamie D Weyandt; Craig B Thompson; Amato J Giaccia; W Kimryn Rathmell
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 6.  The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Authors:  Inga-Marie Schaefer; Jason L Hornick; Judith V M G Bovée
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

7.  LACTB-mediated tumour suppression by increased mitochondrial lipid metabolism.

Authors:  Danilo Cucchi; Claudio Mauro
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

8.  Glutamine Metabolism in Cancer.

Authors:  Ting Li; Christopher Copeland; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia.

Authors:  Luke W Thomas; Cinzia Esposito; Rachel E Morgan; Stacey Price; Jamie Young; Steven P Williams; Lucas A Maddalena; Ultan McDermott; Margaret Ashcroft
Journal:  Commun Biol       Date:  2021-05-21

10.  The β and γ subunits play distinct functional roles in the α2βγ heterotetramer of human NAD-dependent isocitrate dehydrogenase.

Authors:  Tengfei Ma; Yingjie Peng; Wei Huang; Yabing Liu; Jianping Ding
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.